TScan Therapeutics (United States)

Recent papers from TScan Therapeutics (United States)

1. Abstract PR001: Exploiting HIF-driven endogenous retroviral neoantigens to advance kidney cancer immunotherapyCancer Research · 2026
2. TSC-101 Eliminates Recipient Hematopoietic Cells and Demonstrates Potential for Improved Relapse-Free Survival in Patients with AML, ALL, or MDS Undergoing Allogeneic HCT (allo-HCT) with Reduced Intensity Conditioning (RIC): Updated Results from the Phase 1 (ALLOHA) TrialTransplantation and Cellular Therapy · 2026
3. P0023Anti-TL1A and anti-IL-23 combination therapy is superior to its constituent monotherapies in mouse anti-CD40 colitisJournal of Crohn s and Colitis · 2026
4. DF6215, an α-optimized IL-2-Fc fusion, expands immune effectors and drives robust preclinical anti-tumor activityCell Reports Medicine · 2025
5. HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapyCell · 2025
6. A phase 1 trial of TSC-100 and TSC-101, engineered T cell therapies that target minor histocompatibility antigens to eliminate residual disease after hematopoietic cell transplantation.Journal of Clinical Oncology · 2024
7. Initial data from a phase 1, first-in-human clinical trial for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy (TCR-T) for solid tumors.Journal of Clinical Oncology · 2024
8. Abstract CT170: Trial in progress: A phase 1, first in human clinical trial for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy (TCR-T) for solid tumorsCancer Research · 2024
9. Abstract CT151: Trial in progress:A phase 1 trial of TSC-100 and TSC-101, engineered T cell therapies that target minor histocompatibility antigens to eliminate residual disease after hematopoietic cell transplantationCancer Research · 2024
10. Micro-Chimerism Detected By Highly Sensitive AlloHemeTM Solution Is Associated with Treatment Response and Relapse after Allogeneic Stem Cell TransplantationBiology of Blood and Marrow Transplantation · 2024
11. Antigen presentation by B cells enables epitope spreading across an MHC barrierNature Communications · 2023
12. Genetically-biased fertilization in APOBEC1 complementation factor (A1cf) mutant miceScientific Reports · 2022
13. Report of the First International Symposium on NUT CarcinomaClinical Cancer Research · 2022
14. Development of spirulina for the manufacture and oral delivery of protein therapeuticsNature Biotechnology · 2022
15. A toolkit for enhanced reproducibility of RNASeq analysis for synthetic biologistsSynthetic Biology · 2022
16. Prediction of whole-cell transcriptional response with machine learningBioinformatics · 2021
17. Functionally diverse heteromeric traps for ligands of the transforming growth factor-β superfamilyScientific Reports · 2021
18. Online monitoring and control of upstream cell culture process using 1D and 2D‐LC with SegFlow interfaceBiotechnology and Bioengineering · 2021
19. Prediction of Whole-Cell Transcriptional Response with Machine Learning2021
20. Expression and manufacturing of protein therapeutics in spirulina2021